110 related articles for article (PubMed ID: 1908443)
1. Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.
Jetlund O; Thurmann-Nielsen E; Walstad RA
Int J Clin Pharmacol Res; 1991; 11(1):1-6. PubMed ID: 1908443
[TBL] [Abstract][Full Text] [Related]
2. Suitability of cefotiam and cefuroxime axetil for the perioperative short-term prophylaxis in tonsillectomy patients.
Müller R; Böttger C; Wichmann G
Arzneimittelforschung; 2003; 53(2):126-32. PubMed ID: 12642969
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of phenoxymethylpenicillin in tonsils.
Roos K; Grahn E; Ekedahl C; Holm SE
Scand J Infect Dis; 1986; 18(2):125-30. PubMed ID: 3085212
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of phenoxymethylpenicillin and cefadroxil in tonsillar tissue and tonsillar surface fluid.
Strömberg A; Friberg U; Cars O
Eur J Clin Microbiol; 1987 Oct; 6(5):525-9. PubMed ID: 3125047
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
James NC; Donn KH; Collins JJ; Davis IM; Lloyd TL; Hart RW; Powell JR
Antimicrob Agents Chemother; 1991 Sep; 35(9):1860-3. PubMed ID: 1952858
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefuroxime axetil suspension in infants and children.
Powell DA; James NC; Ossi MJ; Nahata MC; Donn KH
Antimicrob Agents Chemother; 1991 Oct; 35(10):2042-5. PubMed ID: 1759825
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bactericidal activity of cefuroxime axetil.
Ginsburg CM; McCracken GH; Petruska M; Olson K
Antimicrob Agents Chemother; 1985 Oct; 28(4):504-7. PubMed ID: 3878129
[TBL] [Abstract][Full Text] [Related]
8. Penetration of oral cefuroxime axetil into the human aqueous humor.
Ghia M; Lotti R; Traverso C; Mattioli F; Martelli A
Ophthalmologica; 1997; 211(4):229-31. PubMed ID: 9216013
[TBL] [Abstract][Full Text] [Related]
9. Comparative investigations on the bioavailability of cefuroxime axetil.
Kees F; Lukassek U; Naber KG; Grobecker H
Arzneimittelforschung; 1991 Aug; 41(8):843-6. PubMed ID: 1781808
[TBL] [Abstract][Full Text] [Related]
10. Measuring antibiotic levels in otitis media.
Thoroddsen E
Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
[TBL] [Abstract][Full Text] [Related]
11. Impact of phenoxymethylpenicillin and clindamycin on microflora in recurrent tonsillitis.
Tunér K; Nord CE
Ann Otol Rhinol Laryngol; 1985; 94(3):278-80. PubMed ID: 3925864
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of the penetration of cefuroxime axetil into human paranasal sinus tissue.
Sudderick RM; Lund VJ; Thomson JP; McCombe A; Mackay IS
Rhinology; 1992 Mar; 30(1):11-6. PubMed ID: 1579807
[TBL] [Abstract][Full Text] [Related]
13. Effect of food on the pharmacokinetics of oral cefuroxime axetil in dogs.
Albarellos GA; Passini SM; Lupi MP; Aramayona S; Lorenzini PM; Montoya L; Landoni MF
J Vet Pharmacol Ther; 2020 May; 43(3):297-302. PubMed ID: 32157713
[TBL] [Abstract][Full Text] [Related]
14. Cefuroxime axetil and penicillin V compared in the treatment of group A beta-hemolytic streptococcal pharyngitis.
Gooch WM; Swenson E; Higbee MD; Cocchetto DM; Evans EC
Clin Ther; 1987; 9(6):670-7. PubMed ID: 3125976
[TBL] [Abstract][Full Text] [Related]
15. Effect of dose and food on the bioavailability of cefuroxime axetil.
Finn A; Straughn A; Meyer M; Chubb J
Biopharm Drug Dispos; 1987; 8(6):519-26. PubMed ID: 3427209
[TBL] [Abstract][Full Text] [Related]
16. IgA levels and carrier rate of Haemophilus influenzae and beta-haemolytic streptococci in children undergoing tonsillectomy.
Ostergaard PA
Acta Pathol Microbiol Scand C; 1976 Aug; 84(4):290-8. PubMed ID: 785944
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability of cefuroxime axetil: comparison of standard and abbreviated methods.
Lang CC; Moreland TA; Davey PG
J Antimicrob Chemother; 1990 Apr; 25(4):645-50. PubMed ID: 2351625
[TBL] [Abstract][Full Text] [Related]
18. Killing kinetics of cefuroxime axetil against Haemophilus influenzae in an in-vitro model simulating serum concentration profiles after oral administration.
Bingen E; Lambert-Zechovsky N; Doit C; Duvignaud P; Georges D; Mariani-Kurkdjian P
J Antimicrob Chemother; 1991 Oct; 28(4):533-6. PubMed ID: 1761448
[TBL] [Abstract][Full Text] [Related]
19. [In-vitro activity of cefuroxime-axetil against pathogens of bacterial infections of the respiratory tract].
Kayser FH; Bille J
Schweiz Rundsch Med Prax; 1990 Nov; 79(45):1383-6. PubMed ID: 2080392
[TBL] [Abstract][Full Text] [Related]
20. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
Stoeckel K; Harell M; Dan M
Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
